Michael Harty (Clare, Independent) | Oireachtas source

It will probably make up part of his answer, but before Dr. Devlin comes in I would like to ask if there is sufficient confidence in this report, or could consultants obtain sufficient confidence in this report to prescribe medicinal cannabis? If they cannot, and the consultant felt they were opening themselves to litigation by prescribing a product, could the Department indemnify a consultant from any adverse effects resulting from their prescribing this product?

I presume that one of the difficulties that consultants have is that they are being asked to prescribe a product which has not got authorisation. There seems to be an unmet need to make this product available to some patients. Could the State indemnify doctors against adverse outcomes by recommending or prescribing these medications?